Please note this presentation will not be recorded
Associate Professor Miguel Renteria is a Group Leader at QIMR Berghofer in Brisbane. His team works at the intersection of genomics, neuroscience and digital health, with the goal of transforming how we detect, track and treat Parkinson’s disease and related neuropsychiatric symptoms. He is the lead investigator of the Australian Parkinson’s Genetics Study (APGS), a nationwide platform enabling large-scale recruitment, harmonised phenotyping, and collaborative discovery and replication.
In this seminar he will present recent APGS-enabled contributions to global PD genetics, including our role in the Global Parkinson’s Genetics Program (GP2) and a recent GWAS meta-analysis identifying 134 PD risk loci. How APGS is evolving beyond case–control genetics to enable more informative, longitudinal characterisation of disease heterogeneity and progression will be discussed. A key focus will be integration of scalable digital phenotyping alongside genomics. This includes longitudinal cognitive assessment, speech and language profiling, and smartphone-based and wearable-based sensor measures. He will discuss opportunities for cross-cohort harmonisation, replication, and mechanism-oriented analyses that link genetic risk to trajectories and targetable biology, highlighting how APGS can support collaborative efforts to bridge the gap between research and care.